Rank | Gene Set | Z-score |
---|---|---|
1 | maturation of SSU-rRNA (GO:0030490) | 7.03644414 |
2 | viral transcription (GO:0019083) | 6.68369892 |
3 | ribosomal small subunit biogenesis (GO:0042274) | 6.64372266 |
4 | translational termination (GO:0006415) | 6.48196344 |
5 | desmosome organization (GO:0002934) | 6.41656103 |
6 | ribosomal small subunit assembly (GO:0000028) | 6.24503021 |
7 | translational elongation (GO:0006414) | 5.60070930 |
8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.27429516 |
9 | interferon-gamma secretion (GO:0072643) | 5.25225867 |
10 | ribosomal large subunit biogenesis (GO:0042273) | 5.22706457 |
11 | translational initiation (GO:0006413) | 5.14738290 |
12 | protein targeting to ER (GO:0045047) | 5.14056168 |
13 | cotranslational protein targeting to membrane (GO:0006613) | 5.12649465 |
14 | cellular protein complex disassembly (GO:0043624) | 5.08870818 |
15 | viral life cycle (GO:0019058) | 5.07463726 |
16 | melanin biosynthetic process (GO:0042438) | 5.06750282 |
17 | protein localization to endoplasmic reticulum (GO:0070972) | 4.87337464 |
18 | hemidesmosome assembly (GO:0031581) | 4.86595510 |
19 | proteasome assembly (GO:0043248) | 4.83609546 |
20 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.83403816 |
21 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.72532617 |
22 | DNA deamination (GO:0045006) | 4.42333987 |
23 | establishment of skin barrier (GO:0061436) | 4.41670687 |
24 | regulation of water loss via skin (GO:0033561) | 4.31073443 |
25 | melanin metabolic process (GO:0006582) | 4.28286585 |
26 | protein complex disassembly (GO:0043241) | 4.22691063 |
27 | formation of translation preinitiation complex (GO:0001731) | 4.19748827 |
28 | ribonucleoprotein complex biogenesis (GO:0022613) | 4.18858467 |
29 | Golgi transport vesicle coating (GO:0048200) | 4.12734704 |
30 | COPI coating of Golgi vesicle (GO:0048205) | 4.12734704 |
31 | low-density lipoprotein particle clearance (GO:0034383) | 4.07126226 |
32 | macromolecular complex disassembly (GO:0032984) | 3.97500388 |
33 | translation (GO:0006412) | 3.87880896 |
34 | secondary metabolite biosynthetic process (GO:0044550) | 3.82634020 |
35 | keratinocyte development (GO:0003334) | 3.77617202 |
36 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.53627878 |
37 | skin morphogenesis (GO:0043589) | 3.51662643 |
38 | protein targeting to membrane (GO:0006612) | 3.48930441 |
39 | ribosome assembly (GO:0042255) | 3.45661563 |
40 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.45139027 |
41 | regulation of early endosome to late endosome transport (GO:2000641) | 3.41144959 |
42 | urea cycle (GO:0000050) | 3.39431982 |
43 | purine nucleobase biosynthetic process (GO:0009113) | 3.36808003 |
44 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.35643802 |
45 | folic acid metabolic process (GO:0046655) | 3.34183693 |
46 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.33205516 |
47 | cell-substrate junction assembly (GO:0007044) | 3.30892977 |
48 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.29110111 |
49 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.29110111 |
50 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.29110111 |
51 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.28492991 |
52 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.28492991 |
53 | protein hydroxylation (GO:0018126) | 3.27652663 |
54 | peptidyl-proline hydroxylation (GO:0019511) | 3.26348058 |
55 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.26214871 |
56 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.26214871 |
57 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.25961781 |
58 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.25570044 |
59 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.21095244 |
60 | keratinization (GO:0031424) | 3.18730474 |
61 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.17552153 |
62 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.16444794 |
63 | cellular component biogenesis (GO:0044085) | 3.15187603 |
64 | protein maturation by protein folding (GO:0022417) | 3.11372991 |
65 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.09264039 |
66 | rRNA processing (GO:0006364) | 3.08018599 |
67 | mRNA catabolic process (GO:0006402) | 3.07744057 |
68 | negative regulation of ligase activity (GO:0051352) | 3.07671298 |
69 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.07671298 |
70 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.06839155 |
71 | urea metabolic process (GO:0019627) | 3.04163526 |
72 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.04110242 |
73 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.02483459 |
74 | regulation of gene silencing by miRNA (GO:0060964) | 3.02483459 |
75 | regulation of gene silencing by RNA (GO:0060966) | 3.02483459 |
76 | nucleobase biosynthetic process (GO:0046112) | 3.02248518 |
77 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.00699024 |
78 | protein retention in ER lumen (GO:0006621) | 2.99693723 |
79 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.99657262 |
80 | ribosome biogenesis (GO:0042254) | 2.99422664 |
81 | epithelial cell-cell adhesion (GO:0090136) | 2.99328840 |
82 | folic acid transport (GO:0015884) | 2.98933813 |
83 | homocysteine metabolic process (GO:0050667) | 2.98658623 |
84 | amino acid salvage (GO:0043102) | 2.95083594 |
85 | L-methionine salvage (GO:0071267) | 2.95083594 |
86 | L-methionine biosynthetic process (GO:0071265) | 2.95083594 |
87 | rRNA metabolic process (GO:0016072) | 2.93909660 |
88 | molting cycle (GO:0042303) | 2.93427672 |
89 | hair cycle (GO:0042633) | 2.93427672 |
90 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.92235660 |
91 | adhesion of symbiont to host (GO:0044406) | 2.90836086 |
92 | rRNA modification (GO:0000154) | 2.90356234 |
93 | regulation of chemokine secretion (GO:0090196) | 2.89230481 |
94 | positive regulation of ligase activity (GO:0051351) | 2.88462448 |
95 | progesterone metabolic process (GO:0042448) | 2.88259557 |
96 | regulation of cholesterol homeostasis (GO:2000188) | 2.87824900 |
97 | L-serine transport (GO:0015825) | 2.83895210 |
98 | intestinal epithelial cell development (GO:0060576) | 2.83065632 |
99 | multicellular organismal water homeostasis (GO:0050891) | 2.83062413 |
100 | protein localization to endosome (GO:0036010) | 2.81510499 |
101 | RNA catabolic process (GO:0006401) | 2.81273738 |
102 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.80776165 |
103 | termination of RNA polymerase III transcription (GO:0006386) | 2.80588290 |
104 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.80588290 |
105 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.79991178 |
106 | cellular copper ion homeostasis (GO:0006878) | 2.79890887 |
107 | GDP-mannose metabolic process (GO:0019673) | 2.79665936 |
108 | midgut development (GO:0007494) | 2.78334040 |
109 | nitrogen cycle metabolic process (GO:0071941) | 2.77794621 |
110 | barbed-end actin filament capping (GO:0051016) | 2.77782386 |
111 | cellular protein complex localization (GO:0034629) | 2.76736328 |
112 | primary alcohol catabolic process (GO:0034310) | 2.75902209 |
113 | glycine metabolic process (GO:0006544) | 2.75891035 |
114 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.75054561 |
115 | diaphragm development (GO:0060539) | 2.73628865 |
116 | positive regulation of cell cycle arrest (GO:0071158) | 2.71976221 |
117 | lung-associated mesenchyme development (GO:0060484) | 2.71483650 |
118 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.69265484 |
119 | cell adhesion mediated by integrin (GO:0033627) | 2.68896815 |
120 | prostaglandin biosynthetic process (GO:0001516) | 2.68444333 |
121 | prostanoid biosynthetic process (GO:0046457) | 2.68444333 |
122 | water homeostasis (GO:0030104) | 2.68245236 |
123 | pinocytosis (GO:0006907) | 2.67870441 |
124 | keratinocyte proliferation (GO:0043616) | 2.67604778 |
125 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.67283044 |
126 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.63918080 |
127 | cellular response to arsenic-containing substance (GO:0071243) | 2.63498994 |
128 | hyaluronan catabolic process (GO:0030214) | 2.63435960 |
129 | amyloid precursor protein catabolic process (GO:0042987) | 2.63042622 |
130 | regulation of gonadotropin secretion (GO:0032276) | 2.62487409 |
131 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.61583634 |
132 | proline biosynthetic process (GO:0006561) | 2.61483573 |
133 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.61462817 |
134 | cellular response to cadmium ion (GO:0071276) | 2.59122823 |
135 | regulation of cellular amine metabolic process (GO:0033238) | 2.59117544 |
136 | galactose metabolic process (GO:0006012) | 2.57176832 |
137 | pentose-phosphate shunt (GO:0006098) | 2.56911074 |
138 | establishment of protein localization to membrane (GO:0090150) | 2.56577817 |
139 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.56286841 |
140 | galactose catabolic process (GO:0019388) | 2.55733110 |
141 | positive regulation of epidermis development (GO:0045684) | 2.55044599 |
142 | pseudouridine synthesis (GO:0001522) | 2.54552985 |
143 | keratinocyte differentiation (GO:0030216) | 2.54165128 |
144 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.54152304 |
145 | basement membrane organization (GO:0071711) | 2.53199861 |
146 | oxidative phosphorylation (GO:0006119) | 2.53079198 |
147 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.52063196 |
148 | cell-substrate adherens junction assembly (GO:0007045) | 2.51681195 |
149 | focal adhesion assembly (GO:0048041) | 2.51681195 |
150 | serine transport (GO:0032329) | 2.51615298 |
151 | NADH metabolic process (GO:0006734) | 2.51311434 |
152 | cyclooxygenase pathway (GO:0019371) | 2.51264912 |
153 | regulation of cholesterol storage (GO:0010885) | 2.49223658 |
154 | transcription from RNA polymerase I promoter (GO:0006360) | 2.49104586 |
155 | regulation of metalloenzyme activity (GO:0048552) | 2.48755622 |
156 | 4-hydroxyproline metabolic process (GO:0019471) | 2.48326587 |
157 | mitotic metaphase plate congression (GO:0007080) | 2.47392687 |
158 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.46643496 |
159 | positive regulation of hair follicle development (GO:0051798) | 2.45172548 |
160 | positive regulation of hair cycle (GO:0042635) | 2.45172548 |
161 | monosaccharide biosynthetic process (GO:0046364) | 2.43608235 |
162 | glucose catabolic process (GO:0006007) | 2.43079255 |
163 | apoptotic cell clearance (GO:0043277) | 2.42887917 |
164 | NADPH regeneration (GO:0006740) | 2.42539564 |
165 | mitotic nuclear envelope reassembly (GO:0007084) | 2.39396585 |
166 | nuclear envelope reassembly (GO:0031468) | 2.39396585 |
167 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.38987849 |
168 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.36769128 |
169 | atrioventricular valve morphogenesis (GO:0003181) | 2.35812261 |
170 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.35729517 |
171 | gluconeogenesis (GO:0006094) | 2.35015963 |
172 | polyketide metabolic process (GO:0030638) | 2.34350184 |
173 | doxorubicin metabolic process (GO:0044598) | 2.34350184 |
174 | daunorubicin metabolic process (GO:0044597) | 2.34350184 |
175 | decidualization (GO:0046697) | 2.34333796 |
176 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.34256771 |
177 | regulation of translational termination (GO:0006449) | 2.34151467 |
178 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.34091910 |
179 | glycosphingolipid catabolic process (GO:0046479) | 2.33685386 |
180 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.32533801 |
181 | stress fiber assembly (GO:0043149) | 2.31009721 |
182 | gap junction assembly (GO:0016264) | 2.30676184 |
183 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.29461688 |
184 | adherens junction assembly (GO:0034333) | 2.28432484 |
185 | hexose biosynthetic process (GO:0019319) | 2.27468201 |
186 | androgen biosynthetic process (GO:0006702) | 2.26847551 |
187 | protein complex localization (GO:0031503) | 2.26676237 |
188 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.24705209 |
189 | tRNA methylation (GO:0030488) | 2.23796355 |
190 | ventricular cardiac muscle cell development (GO:0055015) | 2.23722727 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.47060596 |
2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.15408277 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.44816424 |
4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.80448506 |
5 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.78620334 |
6 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.73612967 |
7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.59283562 |
8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.49327837 |
9 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.45674984 |
10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.35080876 |
11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.31502551 |
12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.24610882 |
13 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.23868157 |
14 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.23446549 |
15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.23108820 |
16 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.20454880 |
17 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.20150557 |
18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.18809814 |
19 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.14314143 |
20 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.11515131 |
21 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.10800699 |
22 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.10800699 |
23 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.10800699 |
24 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.05190887 |
25 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.02907297 |
26 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.02371837 |
27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96837772 |
28 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.93477988 |
29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.91106662 |
30 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.90464714 |
31 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.89304186 |
32 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.86008528 |
33 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.84161614 |
34 | * TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.80930264 |
35 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.80813785 |
36 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.80246677 |
37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.79418283 |
38 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.77193587 |
39 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.76197867 |
40 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.74900298 |
41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.73689971 |
42 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.71678484 |
43 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69511932 |
44 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.69294228 |
45 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.66701869 |
46 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.66576302 |
47 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.64787380 |
48 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.61606579 |
49 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61106711 |
50 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.57585820 |
51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54615427 |
52 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.52775199 |
53 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.51617585 |
54 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.50944230 |
55 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.48432117 |
56 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.47700531 |
57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47371333 |
58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.46765334 |
59 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.46185539 |
60 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.45457741 |
61 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.45051582 |
62 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44121016 |
63 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.40987757 |
64 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.40750488 |
65 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40335766 |
66 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39844995 |
67 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.39320285 |
68 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.38456787 |
69 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.36910375 |
70 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.34609709 |
71 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.33630119 |
72 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.33502922 |
73 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33389419 |
74 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.32532853 |
75 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.32012286 |
76 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.31466735 |
77 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.29188305 |
78 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28658942 |
79 | * NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.28436951 |
80 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.28429763 |
81 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.27669052 |
82 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27059468 |
83 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.26485705 |
84 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26412949 |
85 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.25267052 |
86 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.25191636 |
87 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25065473 |
88 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25065473 |
89 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24500395 |
90 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.23934856 |
91 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.23504570 |
92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23462368 |
93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23389483 |
94 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.21956713 |
95 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.21644737 |
96 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19097117 |
97 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.17807300 |
98 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16828976 |
99 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.15001129 |
100 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.14093930 |
101 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.13293142 |
102 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.12336952 |
103 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12105302 |
104 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.09298201 |
105 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.08393945 |
106 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08144028 |
107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07658936 |
108 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.07185083 |
109 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05904897 |
110 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05473973 |
111 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04716156 |
112 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.04015853 |
113 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.03870154 |
114 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.03717673 |
115 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.02862955 |
116 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.01342562 |
117 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.99984071 |
118 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99661358 |
119 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99507349 |
120 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98153063 |
121 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.97404164 |
122 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.97277136 |
123 | * P68_20966046_ChIP-Seq_HELA_Human | 0.97198320 |
124 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.96002515 |
125 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95990625 |
126 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.95576475 |
127 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95484381 |
128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.94614033 |
129 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.93539929 |
130 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.93058361 |
131 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92625923 |
132 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.91609272 |
133 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.88413037 |
134 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87708014 |
135 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87401752 |
136 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.86843367 |
137 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.86711824 |
138 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86115182 |
139 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.84282949 |
140 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.83621816 |
141 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.82823384 |
142 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.82227429 |
143 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.80810541 |
144 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.79433802 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002796_impaired_skin_barrier | 4.86923483 |
2 | MP0003941_abnormal_skin_development | 3.96735318 |
3 | MP0002254_reproductive_system_inflammat | 3.76639840 |
4 | MP0003693_abnormal_embryo_hatching | 3.57752530 |
5 | MP0009379_abnormal_foot_pigmentation | 3.10979849 |
6 | MP0005501_abnormal_skin_physiology | 3.05311875 |
7 | MP0003806_abnormal_nucleotide_metabolis | 2.96039796 |
8 | MP0010352_gastrointestinal_tract_polyps | 2.93882311 |
9 | MP0008438_abnormal_cutaneous_collagen | 2.80801216 |
10 | MP0004381_abnormal_hair_follicle | 2.78051499 |
11 | MP0010234_abnormal_vibrissa_follicle | 2.74985786 |
12 | MP0003950_abnormal_plasma_membrane | 2.70905979 |
13 | MP0005257_abnormal_intraocular_pressure | 2.65082774 |
14 | MP0004957_abnormal_blastocyst_morpholog | 2.51174108 |
15 | MP0000372_irregular_coat_pigmentation | 2.48953541 |
16 | MP0003453_abnormal_keratinocyte_physiol | 2.44005673 |
17 | MP0002060_abnormal_skin_morphology | 2.32279907 |
18 | MP0001216_abnormal_epidermal_layer | 2.25607217 |
19 | MP0005058_abnormal_lysosome_morphology | 2.25496421 |
20 | MP0003718_maternal_effect | 2.23734392 |
21 | MP0003786_premature_aging | 2.14160380 |
22 | MP0005171_absent_coat_pigmentation | 2.11576184 |
23 | MP0005670_abnormal_white_adipose | 2.09304232 |
24 | MP0005275_abnormal_skin_tensile | 2.07662080 |
25 | MP0001346_abnormal_lacrimal_gland | 2.04543934 |
26 | MP0003186_abnormal_redox_activity | 2.04126902 |
27 | MP0004233_abnormal_muscle_weight | 2.01789594 |
28 | MP0003136_yellow_coat_color | 1.98860915 |
29 | MP0004272_abnormal_basement_membrane | 1.96803040 |
30 | MP0003566_abnormal_cell_adhesion | 1.95915465 |
31 | MP0003705_abnormal_hypodermis_morpholog | 1.85343816 |
32 | MP0000003_abnormal_adipose_tissue | 1.81771031 |
33 | MP0005623_abnormal_meninges_morphology | 1.81564182 |
34 | MP0000467_abnormal_esophagus_morphology | 1.81278708 |
35 | MP0000383_abnormal_hair_follicle | 1.81236414 |
36 | MP0005085_abnormal_gallbladder_physiolo | 1.81082323 |
37 | MP0010771_integument_phenotype | 1.74742882 |
38 | MP0001661_extended_life_span | 1.74692240 |
39 | MP0004782_abnormal_surfactant_physiolog | 1.68760108 |
40 | MP0002098_abnormal_vibrissa_morphology | 1.67666890 |
41 | MP0000762_abnormal_tongue_morphology | 1.66152324 |
42 | MP0000013_abnormal_adipose_tissue | 1.66104832 |
43 | MP0001853_heart_inflammation | 1.62983568 |
44 | MP0000015_abnormal_ear_pigmentation | 1.62842543 |
45 | MP0005023_abnormal_wound_healing | 1.62796427 |
46 | MP0002877_abnormal_melanocyte_morpholog | 1.59347565 |
47 | MP0001542_abnormal_bone_strength | 1.56828066 |
48 | MP0004019_abnormal_vitamin_homeostasis | 1.52484745 |
49 | MP0003111_abnormal_nucleus_morphology | 1.52335602 |
50 | MP0010678_abnormal_skin_adnexa | 1.48913135 |
51 | MP0008875_abnormal_xenobiotic_pharmacok | 1.47474481 |
52 | MP0009840_abnormal_foam_cell | 1.41613587 |
53 | MP0000647_abnormal_sebaceous_gland | 1.41530456 |
54 | MP0008007_abnormal_cellular_replicative | 1.40119263 |
55 | MP0000579_abnormal_nail_morphology | 1.39404724 |
56 | MP0002132_abnormal_respiratory_system | 1.38295812 |
57 | MP0000377_abnormal_hair_follicle | 1.38101678 |
58 | MP0005409_darkened_coat_color | 1.36237007 |
59 | MP0010030_abnormal_orbit_morphology | 1.31935146 |
60 | MP0002163_abnormal_gland_morphology | 1.30386072 |
61 | MP0005075_abnormal_melanosome_morpholog | 1.29328532 |
62 | MP0002139_abnormal_hepatobiliary_system | 1.27594228 |
63 | MP0008260_abnormal_autophagy | 1.27455543 |
64 | MP0004947_skin_inflammation | 1.26557264 |
65 | MP0003077_abnormal_cell_cycle | 1.24880779 |
66 | MP0005375_adipose_tissue_phenotype | 1.24481852 |
67 | MP0005197_abnormal_uvea_morphology | 1.24231000 |
68 | MP0008932_abnormal_embryonic_tissue | 1.22958910 |
69 | MP0002277_abnormal_respiratory_mucosa | 1.22685476 |
70 | MP0005395_other_phenotype | 1.21184316 |
71 | MP0000678_abnormal_parathyroid_gland | 1.18701218 |
72 | MP0005360_urolithiasis | 1.17619518 |
73 | MP0009931_abnormal_skin_appearance | 1.16925001 |
74 | MP0000371_diluted_coat_color | 1.14526976 |
75 | MP0001191_abnormal_skin_condition | 1.13438660 |
76 | MP0000627_abnormal_mammary_gland | 1.11162470 |
77 | MP0004185_abnormal_adipocyte_glucose | 1.09459353 |
78 | MP0008004_abnormal_stomach_pH | 1.06543696 |
79 | MP0000566_synostosis | 1.05161474 |
80 | MP0005083_abnormal_biliary_tract | 1.03539378 |
81 | MP0001243_abnormal_dermal_layer | 1.00702126 |
82 | MP0005666_abnormal_adipose_tissue | 1.00142278 |
83 | MP0001919_abnormal_reproductive_system | 0.97446303 |
84 | MP0000858_altered_metastatic_potential | 0.95487384 |
85 | MP0009053_abnormal_anal_canal | 0.95353845 |
86 | MP0000367_abnormal_coat/_hair | 0.94966783 |
87 | MP0010094_abnormal_chromosome_stability | 0.94577176 |
88 | MP0002009_preneoplasia | 0.94296972 |
89 | MP0005365_abnormal_bile_salt | 0.94096315 |
90 | MP0003315_abnormal_perineum_morphology | 0.93454847 |
91 | MP0005076_abnormal_cell_differentiation | 0.91650347 |
92 | MP0001666_abnormal_nutrient_absorption | 0.91476175 |
93 | MP0002075_abnormal_coat/hair_pigmentati | 0.89221004 |
94 | MP0001851_eye_inflammation | 0.87338138 |
95 | MP0002138_abnormal_hepatobiliary_system | 0.86482307 |
96 | MP0003011_delayed_dark_adaptation | 0.84482661 |
97 | MP0001186_pigmentation_phenotype | 0.83681888 |
98 | MP0002295_abnormal_pulmonary_circulatio | 0.83474360 |
99 | MP0002234_abnormal_pharynx_morphology | 0.81979364 |
100 | MP0005397_hematopoietic_system_phenotyp | 0.80156475 |
101 | MP0001545_abnormal_hematopoietic_system | 0.80156475 |
102 | MP0005332_abnormal_amino_acid | 0.79173666 |
103 | MP0000427_abnormal_hair_cycle | 0.78603413 |
104 | MP0002896_abnormal_bone_mineralization | 0.78373225 |
105 | MP0002938_white_spotting | 0.77895638 |
106 | MP0005451_abnormal_body_composition | 0.77768044 |
107 | MP0005330_cardiomyopathy | 0.77500204 |
108 | MP0005193_abnormal_anterior_eye | 0.76880820 |
109 | MP0003091_abnormal_cell_migration | 0.76731376 |
110 | MP0000750_abnormal_muscle_regeneration | 0.76100464 |
111 | MP0000613_abnormal_salivary_gland | 0.75974846 |
112 | MP0000350_abnormal_cell_proliferation | 0.75120345 |
113 | MP0002111_abnormal_tail_morphology | 0.73932817 |
114 | MP0002970_abnormal_white_adipose | 0.73205225 |
115 | MP0003436_decreased_susceptibility_to | 0.72595993 |
116 | MP0005389_reproductive_system_phenotype | 0.72480232 |
117 | MP0009780_abnormal_chondrocyte_physiolo | 0.71514352 |
118 | MP0001764_abnormal_homeostasis | 0.70284251 |
119 | MP0003191_abnormal_cellular_cholesterol | 0.69717925 |
120 | MP0002282_abnormal_trachea_morphology | 0.69182453 |
121 | MP0005408_hypopigmentation | 0.68484437 |
122 | MP0004858_abnormal_nervous_system | 0.68376577 |
123 | MP0000470_abnormal_stomach_morphology | 0.68216742 |
124 | MP0002089_abnormal_postnatal_growth/wei | 0.68172347 |
125 | MP0000358_abnormal_cell_content/ | 0.67850383 |
126 | MP0006138_congestive_heart_failure | 0.67690420 |
127 | MP0000639_abnormal_adrenal_gland | 0.66482172 |
128 | MP0002971_abnormal_brown_adipose | 0.65490757 |
129 | MP0010329_abnormal_lipoprotein_level | 0.65413311 |
130 | MP0003329_amyloid_beta_deposits | 0.65061531 |
131 | MP0003828_pulmonary_edema | 0.64805216 |
132 | MP0008058_abnormal_DNA_repair | 0.64231256 |
133 | MP0005508_abnormal_skeleton_morphology | 0.64175772 |
134 | MP0002019_abnormal_tumor_incidence | 0.63888211 |
135 | MP0001849_ear_inflammation | 0.62954010 |
136 | MP0002095_abnormal_skin_pigmentation | 0.62637601 |
137 | MP0001958_emphysema | 0.62606498 |
138 | MP0001881_abnormal_mammary_gland | 0.61934350 |
139 | MP0005084_abnormal_gallbladder_morpholo | 0.61442084 |
140 | MP0003638_abnormal_response/metabolism_ | 0.61110216 |
141 | MP0005164_abnormal_response_to | 0.60853235 |
142 | MP0000343_altered_response_to | 0.60712687 |
143 | MP0009384_cardiac_valve_regurgitation | 0.59630335 |
144 | MP0003936_abnormal_reproductive_system | 0.59255094 |
145 | MP0008995_early_reproductive_senescence | 0.58811606 |
146 | MP0000537_abnormal_urethra_morphology | 0.58788889 |
147 | MP0005165_increased_susceptibility_to | 0.57687448 |
148 | MP0005266_abnormal_metabolism | 0.57124842 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fragile nails (HP:0001808) | 5.08071237 |
2 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.44234862 |
3 | Reticulocytopenia (HP:0001896) | 4.36251283 |
4 | Vertebral compression fractures (HP:0002953) | 4.33947089 |
5 | Abnormal hemoglobin (HP:0011902) | 4.04894141 |
6 | Plantar hyperkeratosis (HP:0007556) | 3.93103638 |
7 | Sparse eyelashes (HP:0000653) | 3.75998879 |
8 | Macrocytic anemia (HP:0001972) | 3.74106660 |
9 | Abnormal number of erythroid precursors (HP:0012131) | 3.72469851 |
10 | Onycholysis (HP:0001806) | 3.69868108 |
11 | Distal lower limb muscle weakness (HP:0009053) | 3.57637656 |
12 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.52665873 |
13 | Premature rupture of membranes (HP:0001788) | 3.50867763 |
14 | Hypotrichosis (HP:0001006) | 3.44201852 |
15 | Protrusio acetabuli (HP:0003179) | 3.42257449 |
16 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.34999543 |
17 | Breast hypoplasia (HP:0003187) | 3.30345636 |
18 | Nail dystrophy (HP:0008404) | 3.29641492 |
19 | Alopecia of scalp (HP:0002293) | 3.26895361 |
20 | White forelock (HP:0002211) | 3.22663662 |
21 | Palmoplantar hyperkeratosis (HP:0000972) | 3.16778816 |
22 | Right ventricular cardiomyopathy (HP:0011663) | 3.14540044 |
23 | Milia (HP:0001056) | 3.07029309 |
24 | Palmar hyperkeratosis (HP:0010765) | 3.05959796 |
25 | Premature ovarian failure (HP:0008209) | 3.04610404 |
26 | Woolly hair (HP:0002224) | 3.03525597 |
27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.03145013 |
28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.03145013 |
29 | Abnormality of glycolipid metabolism (HP:0010969) | 3.03145013 |
30 | Patchy hypopigmentation of hair (HP:0011365) | 2.98309672 |
31 | Abnormal blistering of the skin (HP:0008066) | 2.93006486 |
32 | Pallor (HP:0000980) | 2.91758369 |
33 | Rough bone trabeculation (HP:0100670) | 2.88820456 |
34 | Oral leukoplakia (HP:0002745) | 2.85600059 |
35 | Trismus (HP:0000211) | 2.83522379 |
36 | Elbow flexion contracture (HP:0002987) | 2.67080166 |
37 | Erythema (HP:0010783) | 2.60504773 |
38 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.57876396 |
39 | Axonal loss (HP:0003447) | 2.57528390 |
40 | Fragile skin (HP:0001030) | 2.55425999 |
41 | Parakeratosis (HP:0001036) | 2.55090175 |
42 | Secondary amenorrhea (HP:0000869) | 2.51655774 |
43 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.50971570 |
44 | Osteolytic defects of the hand bones (HP:0009699) | 2.50971570 |
45 | Stenosis of the external auditory canal (HP:0000402) | 2.48707597 |
46 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.48014266 |
47 | Abnormality of glycolysis (HP:0004366) | 2.47875287 |
48 | Concave nail (HP:0001598) | 2.46690312 |
49 | Ulnar bowing (HP:0003031) | 2.45199010 |
50 | Absent thumb (HP:0009777) | 2.43875312 |
51 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.37688531 |
52 | Congenital, generalized hypertrichosis (HP:0004540) | 2.37557182 |
53 | Abnormality of the umbilical cord (HP:0010881) | 2.36036351 |
54 | Abnormal trabecular bone morphology (HP:0100671) | 2.35148206 |
55 | Carpal bone hypoplasia (HP:0001498) | 2.35001773 |
56 | Fused cervical vertebrae (HP:0002949) | 2.33227290 |
57 | Cervical subluxation (HP:0003308) | 2.33054121 |
58 | Areflexia of lower limbs (HP:0002522) | 2.30545170 |
59 | Mitral stenosis (HP:0001718) | 2.29717195 |
60 | Lip pit (HP:0100267) | 2.29286028 |
61 | Acanthosis nigricans (HP:0000956) | 2.28927724 |
62 | Xanthomatosis (HP:0000991) | 2.28828266 |
63 | 11 pairs of ribs (HP:0000878) | 2.26743055 |
64 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.26189020 |
65 | Abnormality of the axillary hair (HP:0100134) | 2.25454602 |
66 | Abnormality of secondary sexual hair (HP:0009888) | 2.25454602 |
67 | Atrophic scars (HP:0001075) | 2.25067673 |
68 | Esophageal atresia (HP:0002032) | 2.24603544 |
69 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.22727230 |
70 | Hypoalphalipoproteinemia (HP:0003233) | 2.21742993 |
71 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.21656990 |
72 | Abnormality of carpal bone ossification (HP:0006257) | 2.20399528 |
73 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.18525643 |
74 | Increased serum pyruvate (HP:0003542) | 2.18461708 |
75 | Abnormality of nail color (HP:0100643) | 2.16182457 |
76 | Erythroderma (HP:0001019) | 2.13933684 |
77 | Hypokinesia (HP:0002375) | 2.13521400 |
78 | Thick nail (HP:0001805) | 2.13177874 |
79 | Short nail (HP:0001799) | 2.09038758 |
80 | Epidermoid cyst (HP:0200040) | 2.07181148 |
81 | Hyperglycinuria (HP:0003108) | 2.06830172 |
82 | Birth length less than 3rd percentile (HP:0003561) | 2.06812423 |
83 | Absent radius (HP:0003974) | 2.05952615 |
84 | Popliteal pterygium (HP:0009756) | 2.05906887 |
85 | Ocular albinism (HP:0001107) | 2.04233639 |
86 | Upper limb amyotrophy (HP:0009129) | 2.03758556 |
87 | Distal upper limb amyotrophy (HP:0007149) | 2.03758556 |
88 | Distal lower limb amyotrophy (HP:0008944) | 2.03603005 |
89 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.03580843 |
90 | Vascular calcification (HP:0004934) | 2.02650005 |
91 | Amniotic constriction ring (HP:0009775) | 2.02556589 |
92 | Abnormality of placental membranes (HP:0011409) | 2.02556589 |
93 | Wormian bones (HP:0002645) | 2.02468051 |
94 | Cardiovascular calcification (HP:0011915) | 2.00773088 |
95 | Ankle contracture (HP:0006466) | 2.00250856 |
96 | Intrahepatic cholestasis (HP:0001406) | 2.00241124 |
97 | Multiple enchondromatosis (HP:0005701) | 1.99864583 |
98 | Advanced eruption of teeth (HP:0006288) | 1.98955740 |
99 | Pili torti (HP:0003777) | 1.98715838 |
100 | Hypohidrosis (HP:0000966) | 1.97275913 |
101 | Selective tooth agenesis (HP:0001592) | 1.95860310 |
102 | Conical tooth (HP:0000698) | 1.94774947 |
103 | Natal tooth (HP:0000695) | 1.94602359 |
104 | Abnormal ossification of hand bones (HP:0005921) | 1.94409191 |
105 | Absent forearm bone (HP:0003953) | 1.93434789 |
106 | Aplasia involving forearm bones (HP:0009822) | 1.93434789 |
107 | Hyperglycinemia (HP:0002154) | 1.92070658 |
108 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.89391705 |
109 | Single umbilical artery (HP:0001195) | 1.89391705 |
110 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.89391705 |
111 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.89305575 |
112 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.89305575 |
113 | Hypobetalipoproteinemia (HP:0003563) | 1.88929664 |
114 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.88571790 |
115 | Ridged nail (HP:0001807) | 1.88553021 |
116 | Pustule (HP:0200039) | 1.88183138 |
117 | Entropion (HP:0000621) | 1.87972333 |
118 | Progressive muscle weakness (HP:0003323) | 1.87220089 |
119 | Abnormal hair laboratory examination (HP:0003328) | 1.86452874 |
120 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.85246409 |
121 | Follicular hyperkeratosis (HP:0007502) | 1.85224135 |
122 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.85203616 |
123 | Abnormality of the Achilles tendon (HP:0005109) | 1.84991214 |
124 | Thrombocytosis (HP:0001894) | 1.84107618 |
125 | Abnormality of the acetabulum (HP:0003170) | 1.83247864 |
126 | Achilles tendon contracture (HP:0001771) | 1.82365190 |
127 | Spastic paraparesis (HP:0002313) | 1.82236930 |
128 | Horseshoe kidney (HP:0000085) | 1.81777348 |
129 | Upper limb muscle weakness (HP:0003484) | 1.81204178 |
130 | Death in infancy (HP:0001522) | 1.81018653 |
131 | Pterygium (HP:0001059) | 1.80849993 |
132 | Prolonged neonatal jaundice (HP:0006579) | 1.80077886 |
133 | Anhidrosis (HP:0000970) | 1.79400421 |
134 | Myocardial infarction (HP:0001658) | 1.79009880 |
135 | Hypolipoproteinemia (HP:0010981) | 1.76510703 |
136 | Colon cancer (HP:0003003) | 1.76359928 |
137 | Missing ribs (HP:0000921) | 1.75305842 |
138 | Exertional dyspnea (HP:0002875) | 1.74965106 |
139 | Spinal cord compression (HP:0002176) | 1.74644009 |
140 | Sparse scalp hair (HP:0002209) | 1.74490261 |
141 | Ragged-red muscle fibers (HP:0003200) | 1.73753348 |
142 | Gout (HP:0001997) | 1.73270809 |
143 | Increased hepatocellular lipid droplets (HP:0006565) | 1.73204402 |
144 | Microretrognathia (HP:0000308) | 1.72526978 |
145 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.72318716 |
146 | Paraparesis (HP:0002385) | 1.71593401 |
147 | Iris hypopigmentation (HP:0007730) | 1.71027621 |
148 | Abnormality of alanine metabolism (HP:0010916) | 1.69945146 |
149 | Hyperalaninemia (HP:0003348) | 1.69945146 |
150 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.69945146 |
151 | Increased connective tissue (HP:0009025) | 1.67565988 |
152 | Abnormal gallbladder physiology (HP:0012438) | 1.65400736 |
153 | Cholecystitis (HP:0001082) | 1.65400736 |
154 | Skin nodule (HP:0200036) | 1.64987062 |
155 | Tongue fasciculations (HP:0001308) | 1.62623680 |
156 | Cerebral aneurysm (HP:0004944) | 1.61801312 |
157 | Hypoplasia of dental enamel (HP:0006297) | 1.60877987 |
158 | Cerebral inclusion bodies (HP:0100314) | 1.60656161 |
159 | Generalized amyotrophy (HP:0003700) | 1.60160415 |
160 | Abnormal auditory evoked potentials (HP:0006958) | 1.59332335 |
161 | Dry hair (HP:0011359) | 1.59202873 |
162 | Abnormal hand bone ossification (HP:0010660) | 1.59136397 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 5.50002767 |
2 | PIM2 | 3.63813449 |
3 | BUB1 | 3.30315550 |
4 | WEE1 | 2.90426603 |
5 | NME2 | 2.83567754 |
6 | MST4 | 2.82274428 |
7 | RPS6KB2 | 2.69864598 |
8 | MAPKAPK3 | 2.57803793 |
9 | MAP3K3 | 2.56438992 |
10 | TESK1 | 2.31079705 |
11 | ZAK | 2.28308809 |
12 | MAP2K2 | 2.03917701 |
13 | PRPF4B | 1.85734050 |
14 | MAP3K11 | 1.85400741 |
15 | IRAK3 | 1.84903223 |
16 | LMTK2 | 1.83662802 |
17 | MST1R | 1.79772785 |
18 | DYRK3 | 1.63284837 |
19 | PTK2 | 1.61218371 |
20 | RPS6KA4 | 1.56923690 |
21 | SIK1 | 1.56130110 |
22 | BRSK2 | 1.55934796 |
23 | PLK4 | 1.52763579 |
24 | ICK | 1.50504448 |
25 | IKBKB | 1.46372656 |
26 | TRIB3 | 1.46081342 |
27 | EIF2AK1 | 1.45485832 |
28 | TESK2 | 1.45330157 |
29 | TLK1 | 1.45292980 |
30 | TTK | 1.42180555 |
31 | RIPK1 | 1.41205017 |
32 | NME1 | 1.39811704 |
33 | LRRK2 | 1.38846539 |
34 | VRK1 | 1.35730236 |
35 | MYLK | 1.35217383 |
36 | BCKDK | 1.33283338 |
37 | TSSK6 | 1.29416478 |
38 | STK10 | 1.28581928 |
39 | MAP3K14 | 1.26127834 |
40 | AURKA | 1.24568326 |
41 | ABL2 | 1.22468826 |
42 | FER | 1.19932941 |
43 | AURKB | 1.16200071 |
44 | PAK4 | 1.15103568 |
45 | DDR2 | 1.13604653 |
46 | STK16 | 1.11112408 |
47 | MOS | 1.10613428 |
48 | STK24 | 1.04736845 |
49 | SRPK1 | 1.04022317 |
50 | NEK1 | 1.03713826 |
51 | MAP3K8 | 1.03668209 |
52 | PLK1 | 1.00580609 |
53 | PDGFRA | 0.98629862 |
54 | NTRK1 | 0.97978368 |
55 | EIF2AK2 | 0.97842611 |
56 | LIMK1 | 0.94759976 |
57 | STK38L | 0.94705508 |
58 | DAPK3 | 0.92905857 |
59 | ARAF | 0.92614139 |
60 | PRKCI | 0.92611155 |
61 | TTN | 0.91465129 |
62 | TGFBR1 | 0.91447133 |
63 | BRAF | 0.91376668 |
64 | MAP3K9 | 0.90458337 |
65 | PIM1 | 0.89644331 |
66 | AKT3 | 0.88236611 |
67 | TGFBR2 | 0.86862250 |
68 | TYK2 | 0.86234680 |
69 | PLK3 | 0.85373626 |
70 | PDPK1 | 0.82673225 |
71 | SCYL2 | 0.81842308 |
72 | SMG1 | 0.80057047 |
73 | BMPR2 | 0.79497525 |
74 | NEK9 | 0.78965014 |
75 | RPS6KA5 | 0.77746916 |
76 | MAP3K2 | 0.76619217 |
77 | STK38 | 0.75691762 |
78 | EEF2K | 0.73819238 |
79 | AKT2 | 0.72866049 |
80 | MTOR | 0.71385381 |
81 | EPHB2 | 0.70736254 |
82 | MAPK15 | 0.69862455 |
83 | TAOK2 | 0.69196722 |
84 | PRKD3 | 0.69119789 |
85 | KDR | 0.68746255 |
86 | PRKG2 | 0.67883136 |
87 | MAPKAPK2 | 0.64940637 |
88 | LATS2 | 0.64833721 |
89 | ILK | 0.64261108 |
90 | PBK | 0.64063932 |
91 | PDK2 | 0.63705472 |
92 | PAK2 | 0.63548362 |
93 | CDK7 | 0.63485435 |
94 | CHUK | 0.62399377 |
95 | NEK6 | 0.61709590 |
96 | MAPKAPK5 | 0.61570982 |
97 | MAP3K12 | 0.61427312 |
98 | MAP2K6 | 0.60681316 |
99 | TRPM7 | 0.59502248 |
100 | ERBB3 | 0.59265810 |
101 | PAK1 | 0.58326560 |
102 | PRKD2 | 0.57190035 |
103 | GSK3A | 0.57001692 |
104 | BCR | 0.54412975 |
105 | BRSK1 | 0.53548452 |
106 | GRK5 | 0.52182225 |
107 | CAMK2G | 0.51887416 |
108 | MAP2K1 | 0.51496814 |
109 | ERN1 | 0.51148366 |
110 | FLT3 | 0.50737967 |
111 | MAP3K1 | 0.50248567 |
112 | EIF2AK3 | 0.49628608 |
113 | CSNK2A1 | 0.48096044 |
114 | LATS1 | 0.46148702 |
115 | MAPK11 | 0.45527842 |
116 | CAMKK2 | 0.44498299 |
117 | TAOK1 | 0.44117537 |
118 | MET | 0.43460306 |
119 | CSNK2A2 | 0.42732847 |
120 | MAPK4 | 0.41403065 |
121 | MAP2K3 | 0.41226929 |
122 | TBK1 | 0.40681975 |
123 | RPS6KA2 | 0.40062713 |
124 | MAPK7 | 0.38977994 |
125 | MUSK | 0.38219757 |
126 | MAP3K5 | 0.37476246 |
127 | CDK8 | 0.37279067 |
128 | CDK6 | 0.36339482 |
129 | PASK | 0.35983311 |
130 | RPS6KA1 | 0.35727244 |
131 | KSR2 | 0.34349550 |
132 | GRK7 | 0.32895788 |
133 | CHEK2 | 0.32697268 |
134 | RAF1 | 0.32271075 |
135 | CDK9 | 0.31893492 |
136 | ERBB4 | 0.31654750 |
137 | IRAK1 | 0.31119991 |
138 | BMX | 0.28889136 |
139 | ADRBK1 | 0.26064886 |
140 | CAMK2D | 0.25157913 |
141 | PTK6 | 0.24256225 |
142 | CDK12 | 0.24182983 |
143 | MELK | 0.24034531 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 5.74920447 |
2 | Proteasome_Homo sapiens_hsa03050 | 4.30564148 |
3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.10995462 |
4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.95081227 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 2.85048769 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.29949001 |
7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.28470279 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.10462032 |
9 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.07323508 |
10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.05242633 |
11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.95155586 |
12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.93234231 |
13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.92514175 |
14 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.92054242 |
15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.90122404 |
16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.89367598 |
17 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.87166467 |
18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.84031391 |
19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.80022551 |
20 | DNA replication_Homo sapiens_hsa03030 | 1.76413114 |
21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.75055721 |
22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.74916995 |
23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.70349141 |
24 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.67459400 |
25 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.66045058 |
26 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.62188068 |
27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.56022618 |
28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.52418614 |
29 | Lysosome_Homo sapiens_hsa04142 | 1.51583903 |
30 | RNA transport_Homo sapiens_hsa03013 | 1.50646390 |
31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.50509337 |
32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.46014684 |
33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.40567726 |
34 | Spliceosome_Homo sapiens_hsa03040 | 1.40484043 |
35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.36572234 |
36 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35637781 |
37 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.34186844 |
38 | Huntingtons disease_Homo sapiens_hsa05016 | 1.32541075 |
39 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.28773464 |
40 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.28627191 |
41 | Mismatch repair_Homo sapiens_hsa03430 | 1.27681261 |
42 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.25223620 |
43 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.21631568 |
44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.20448300 |
45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.19796518 |
46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19264058 |
47 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.17450298 |
48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.16081092 |
49 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.15585009 |
50 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.14469405 |
51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.14288361 |
52 | Bladder cancer_Homo sapiens_hsa05219 | 1.10452421 |
53 | Homologous recombination_Homo sapiens_hsa03440 | 1.10352707 |
54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09797072 |
55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09169881 |
56 | Base excision repair_Homo sapiens_hsa03410 | 1.07493774 |
57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.06742494 |
58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04703081 |
59 | Sulfur relay system_Homo sapiens_hsa04122 | 1.03339543 |
60 | Prion diseases_Homo sapiens_hsa05020 | 1.03256188 |
61 | Mineral absorption_Homo sapiens_hsa04978 | 0.96491798 |
62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.93877662 |
63 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91205941 |
64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88888520 |
65 | Cell cycle_Homo sapiens_hsa04110 | 0.86793234 |
66 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.85976269 |
67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.83728936 |
68 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81688108 |
69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.79688730 |
70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78636859 |
71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78152303 |
72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77905217 |
73 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77210975 |
74 | Purine metabolism_Homo sapiens_hsa00230 | 0.76054505 |
75 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.75456931 |
76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.74934061 |
77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74755639 |
78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74286680 |
79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73295541 |
80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.71947312 |
81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70170633 |
82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69871932 |
83 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.67237700 |
84 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.67108372 |
85 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66019673 |
86 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64472117 |
87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.63289435 |
88 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63054089 |
89 | Focal adhesion_Homo sapiens_hsa04510 | 0.63034938 |
90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62918600 |
91 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.62307178 |
92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62241718 |
93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62224374 |
94 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.58411251 |
95 | RNA degradation_Homo sapiens_hsa03018 | 0.56169557 |
96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55558481 |
97 | Peroxisome_Homo sapiens_hsa04146 | 0.54568225 |
98 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.53032240 |
99 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.51597513 |
100 | Bile secretion_Homo sapiens_hsa04976 | 0.50110608 |
101 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.49932863 |
102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49064485 |
103 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45890420 |
104 | Endocytosis_Homo sapiens_hsa04144 | 0.45827889 |
105 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.44975291 |
106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43330840 |
107 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.43188747 |
108 | Apoptosis_Homo sapiens_hsa04210 | 0.43055790 |
109 | Adherens junction_Homo sapiens_hsa04520 | 0.42070441 |
110 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41450818 |
111 | Amoebiasis_Homo sapiens_hsa05146 | 0.39351781 |
112 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.37855168 |
113 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37002838 |
114 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35140027 |
115 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35138785 |
116 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34610141 |
117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34523973 |
118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.33489799 |
119 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.33122333 |
120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32587668 |
121 | Tight junction_Homo sapiens_hsa04530 | 0.31968903 |
122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31397542 |
123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31130104 |
124 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30746372 |
125 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.30324917 |
126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29124515 |
127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28552274 |
128 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.28391575 |
129 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27356946 |
130 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26308092 |
131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24852417 |
132 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.19263623 |
133 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.19006738 |
134 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.18203704 |